Loading...
Market
Story
GLP-1 Agonists, Including Semaglutide, May Reduce Addiction and Overdose Risks, Study Finds
Oct 17, 2024, 05:32 AM
A new study suggests that GLP-1 agonist medications, such as Ozempic, Wegovy, Mounjaro, Trulicity, and semaglutide, which are commonly used for diabetes management and weight loss, may also help reduce addictive behaviors and prevent opioid overdose. The study, which analyzed 1.3 million health records, found that among people with alcoholism, rates of alcohol intoxication were 50% lower, and among those with opioid addiction, overdose rates were 40% lower. Additionally, these medications were associated with 40% lower rates of hospitalizations for heroin overdose.
View original story
Similar markets
Yes • 50%
No • 50%
Yes • 50%
No • 50%
American Medical Association • 25%
Centers for Disease Control and Prevention • 25%
World Health Organization • 25%
Other • 25%
Confirms current findings • 25%
Shows no significant change • 25%
Shows increased risk • 25%
Shows reduced risk but less than current findings • 25%
Yes • 50%
No • 50%
Yes • 50%
No • 50%
Yes • 50%
No • 50%
Confirms link • 25%
Refutes link • 25%
Inconclusive • 25%
No publication • 25%
